These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11340797)

  • 21. Drooling in Parkinson's disease: a review.
    Srivanitchapoom P; Pandey S; Hallett M
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1109-18. PubMed ID: 25200111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
    Turk-Gonzales M; Odderson IR
    Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.
    Karakoc M; Yon MI; Cakmakli GY; Ulusoy EK; Gulunay A; Oztekin N; Ak F
    Neurol Sci; 2016 Dec; 37(12):1987-1991. PubMed ID: 27613712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drooling, Swallowing Difficulties and Health Related Quality of Life in Parkinson's Disease Patients.
    Arboleda-Montealegre GY; Cano-de-la-Cuerda R; Fernández-de-Las-Peñas C; Sanchez-Camarero C; Ortega-Santiago R
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diurnal and nocturnal drooling in Parkinson's disease.
    Kalf JG; Bloem BR; Munneke M
    J Neurol; 2012 Jan; 259(1):119-23. PubMed ID: 21698387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drooling rating scales in Parkinson's disease: A systematic review.
    Nascimento D; Carmona J; Mestre T; Ferreira JJ; Guimarães I
    Parkinsonism Relat Disord; 2021 Oct; 91():173-180. PubMed ID: 34583888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialorrhea in Parkinson's Disease.
    Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drooling is no early sign of dysphagia in Parkinson's disease.
    Nienstedt JC; Buhmann C; Bihler M; Niessen A; Plaetke R; Gerloff C; Pflug C
    Neurogastroenterol Motil; 2018 Apr; 30(4):e13259. PubMed ID: 29178420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotigotine may control drooling in patients with Parkinson's Disease: Preliminary findings.
    Schirinzi T; Imbriani P; D'Elia A; Di Lazzaro G; Mercuri NB; Pisani A
    Clin Neurol Neurosurg; 2017 May; 156():63-65. PubMed ID: 28342306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
    Erasmus CE; van Hulst K; Scheffer AR; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
    Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Swallowing and esophageal function in Parkinson's disease.
    Johnston BT; Li Q; Castell JA; Castell DO
    Am J Gastroenterol; 1995 Oct; 90(10):1741-6. PubMed ID: 7572887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sialorrhea in Parkinson's disease: a review.
    Chou KL; Evatt M; Hinson V; Kompoliti K
    Mov Disord; 2007 Dec; 22(16):2306-13. PubMed ID: 17659637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Swallowing in Parkinson's disease: clinical issues and management.
    Miller N
    Neurodegener Dis Manag; 2017 Jun; 7(3):205-217. PubMed ID: 28632108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interests of the ultrasound-guidance in the treatment of drooling through botulinum toxin injections, our experience over 10 years].
    Mailly M; Rebours C; Koskas P; Klap P; Ayache D; Cohen M
    J Stomatol Oral Maxillofac Surg; 2017 Feb; 118(1):5-10. PubMed ID: 28330576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of drooling in Parkinson's disease with botulinum toxin.
    Jost WH
    Mov Disord; 1999 Nov; 14(6):1057. PubMed ID: 10584695
    [No Abstract]   [Full Text] [Related]  

  • 37. Debilitating consequences of drooling.
    Bloem BR; Kalf JG; van de Kerkhof PC; Zwarts MJ
    J Neurol; 2009 Aug; 256(8):1382-3. PubMed ID: 19412723
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound-Guided Botulinum Toxin Injections into the Salivary Glands for the Treatment of Drooling.
    Abboud WA; Nadel S; Hassin-Baer S; Arad A; Dobriyan A; Yahalom R
    Isr Med Assoc J; 2019 Feb; 21(2):116-119. PubMed ID: 30772963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.